From staff reports
Hilliard named 2017-2018 APhA president-elect
APhA has announced its new officers for 2017-2018.
Naltrexone plus prolonged exposure therapy helps alcohol-dependent PTSD patients
New study shows that simultaneous treatment of alcohol dependence and PTSD is more effective than either treatment would be alone.
Concomitant control of BP, cholesterol is difficult
Many patients suffer from both hypertension and high cholesterol, putting them at greater risk of coronary heart disease (CHD). Controlling the hypertension and high cholesterol would reduce CHD risk by 50% or more, but less than a third of patients have achieved adequate control of both, according to an online study in Circulation.
NCPA CEO testifies before congressional committee
B. Douglas Hoey, CEO of the National Community Pharmacists Association, this week testified before a congressional committee considering tightening FDA oversight of compounding pharmacies following last year’s New England Compounding Center’s fungal meningitis tragedy.
Former HHS Secretary urging more FDA oversight of compounding pharmacies
Former Health and Human Services Secretary Tommy Thompson is leading a group that wants greater FDA oversight of compounding pharmacies, including restrictions on the drugs they can produce.
Weitzel named Editor-in-Chief of the APhA DrugInfoLine
APhA DrugInfoLine, an online publication that provides drug-news updates to members of the American Pharmacists Association (APhA), has named Kristin W. Weitzel editor-in-chief.
Silvester named ASHP’s vice president, accreditation services
Janet Silvester, former president and board member of the American Society of Health-System Pharmacists (ASHP), will rejoin that organization as its vice president of accreditation services.
FDA warns against prolonged use of magnesium sulfate to stop preterm labor
FDA advised healthcare professionals not to use magnesium sulfate injection for more than 5-7 days to stop preterm labor in pregnant women.
ACP: Decrease use of intensive insulin therapy in hospitalized patients
a new, evidence-based paper by the American College of Physicians Clinical Guidelines Committee suggests intensive insulin therapy does not show a consistent benefit and may lead to harm.
Study: Glaucoma eyedrops may cause droopy eyelids
new study suggests prostaglandin analogues may cause droopy eyelids and other side effects that can hamper vision.